CNS Pharmaceuticals Inc. (CNSP)
NASDAQ · Healthcare
CNS Pharmaceuticals Inc. Net Income 2020–2025
CNS Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- CNS Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -4.9 M, a 14.78% increase year-over-year.
- CNS Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -16.5 M.
- CNS Pharmaceuticals Inc. annual net income for 2025 was -15.9 M, a 6.68% increase from 2024.
- CNS Pharmaceuticals Inc. annual net income for 2024 was -14.9 M, a 21.18% decrease from 2023.
- CNS Pharmaceuticals Inc. annual net income for 2023 was -18.9 M, a 23.42% increase from 2022.
- CNS Pharmaceuticals Inc. annual net income for 2022 was -15.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CNS Pharmaceuticals Inc. Net Income — FAQ
CNS Pharmaceuticals Inc. (CNSP) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is CNS Pharmaceuticals Inc.'s net income?
CNS Pharmaceuticals Inc. (CNSP) reported net income of -$16M for fiscal 2025.
Where can I see CNSP's net income history?
The chart and table above show CNS Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.